What is a stock summary page? Click here for an overview.
Business Description
Vincerx Pharma Inc
NAICS : 541714
SIC : 2836
ISIN : US92731L1061
Share Class Description:
VINC: Ordinary SharesDescription
Vincerx Pharma Inc is a clinical-stage biopharmaceutical company focused on development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The company's activities are conducted in the United States. It focuses on developing, using, manufacturing, commercializing, sublicensing, and distributing a clinical-stage and follow-on small molecule drug program and a preclinical-stage bioconjugation/next-generation ADC platform.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.04 | |||||
| Equity-to-Asset | 0.34 | |||||
| Debt-to-Equity | 0.6 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 39.6 | |||||
| 3-Year EPS without NRI Growth Rate | 39.8 | |||||
| 3-Year FCF Growth Rate | 32.6 | |||||
| 3-Year Book Growth Rate | -76.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 73 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.52 | |||||
| 9-Day RSI | 42.22 | |||||
| 14-Day RSI | 34.94 | |||||
| 3-1 Month Momentum % | -76.84 | |||||
| 6-1 Month Momentum % | -92.14 | |||||
| 12-1 Month Momentum % | -99.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.21 | |||||
| Quick Ratio | 1.21 | |||||
| Cash Ratio | 0.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.6 | |||||
| Shareholder Yield % | -1111.17 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -396.96 | |||||
| ROA % | -203.81 | |||||
| ROIC % | -605.36 | |||||
| 3-Year ROIIC % | -223.91 | |||||
| ROC (Joel Greenblatt) % | -1530.6 | |||||
| ROCE % | -379.04 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.54 | |||||
| Price-to-Tangible-Book | 0.54 | |||||
| EV-to-EBIT | 0.11 | |||||
| EV-to-EBITDA | 0.12 | |||||
| EV-to-FCF | 0.14 | |||||
| Price-to-Net-Current-Asset-Value | 1.31 | |||||
| Earnings Yield (Greenblatt) % | 909.09 | |||||
| FCF Yield % | -1774.93 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VINC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vincerx Pharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -19.25 | ||
| Beta | 1.51 | ||
| 3-Year Sharpe Ratio | -0.14 | ||
| 3-Year Sortino Ratio | -0.24 | ||
| Volatility % | 119.56 | ||
| 14-Day RSI | 34.94 | ||
| 14-Day ATR ($) | 0.12765 | ||
| 20-Day SMA ($) | 0.692085 | ||
| 12-1 Month Momentum % | -99.14 | ||
| 52-Week Range ($) | 0.4843 - 136.8 | ||
| Shares Outstanding (Mil) | 2.24 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vincerx Pharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vincerx Pharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vincerx Pharma Inc Frequently Asked Questions
What is Vincerx Pharma Inc(VINC)'s stock price today?
The current price of VINC is $0.66. The 52 week high of VINC is $136.80 and 52 week low is $0.48.
When is next earnings date of Vincerx Pharma Inc(VINC)?
The next earnings date of Vincerx Pharma Inc(VINC) is 2025-05-14 Est..
Does Vincerx Pharma Inc(VINC) pay dividends? If so, how much?
Vincerx Pharma Inc(VINC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers